Article
Silver Spring, Md. - The FDA Dermatologic and Ophthalmic AdvisoryCommittee, by an 8-2 vote, on May 23 recommended approval of alefacept,a systemic drug for the treatment of chronic plaque psoriasis.
Nektar's Jonathan Zalevsky, PhD, Dives Into Rezpegaldesleukin Fast Track Designation for Atopic Dermatitis
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
New Data on Bimekizumab’s Long-term HS Efficacy
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
Potential 2025 Tax Law Changes: What Dermatologists Should Know
Daily Derm Times: February 13, 2025